Besides, we failed to analyze the effect of POLD1 mutation on HCC pathogenesis and patients’ survival, because there were only 4 patients with POLD1 mutation among 373 HCC patients in TCGA-LIHC dataset, and no patient carried POLD1 proofreading domain mutation (data not shown). This evidence concerns the gene POLD1 and hepatocellular carcinoma.